Recent INKT News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 02:40:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 09:21:22 PM
- MiNK Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Highlight Platform Expansion Across iNKT Cell Therapy Programs • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- MiNK Therapeutics shares jump 80% after C-Further partnership announcement • IH Market News • 03/10/2026 11:15:59 AM
- MiNK Therapeutics Announces Collaboration with C-Further to Advance PRAME-Targeted iNKT Cell Therapy for Pediatric Cancers • GlobeNewswire Inc. • 03/10/2026 09:30:00 AM
- MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia • GlobeNewswire Inc. • 02/04/2026 02:30:00 AM
- MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease • GlobeNewswire Inc. • 01/08/2026 05:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 09:05:22 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/10/2025 09:23:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/08/2025 09:10:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 09:10:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 09:10:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/03/2025 09:10:04 PM
- MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors • GlobeNewswire Inc. • 11/20/2025 04:42:32 PM
- MiNK Therapeutics Reports Q3 2025 Results and Accelerates iNKT Platform Toward Pivotal Development Across Oncology, Pulmonary Disease, and Transplantation • GlobeNewswire Inc. • 11/14/2025 12:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2025 09:57:32 PM
- MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025 • GlobeNewswire Inc. • 11/07/2025 02:00:00 PM
- MiNK Therapeutics to Report Third Quarter 2025 Financial Results and Highlight Clinical and Corporate Milestones Advancing iNKT Platform Toward Pivotal Development • GlobeNewswire Inc. • 11/05/2025 02:07:20 PM
- MiNK Therapeutics to Present Late-Breaking Data on AgenT-797 in Solid Tumors at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting • GlobeNewswire Inc. • 10/30/2025 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/29/2025 01:14:53 PM
- MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors • GlobeNewswire Inc. • 09/29/2025 11:30:00 AM
- MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA • GlobeNewswire Inc. • 09/25/2025 11:30:00 AM
- MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development • GlobeNewswire Inc. • 09/18/2025 11:30:00 AM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
